The active ingredient in Genfulin^® is molgramostim (recombinant human granulocyte/ macrophage colony-stimulating factor,
rhGM-CSF [rDNA origin]) produced by GenScis patented E.coli secretion technology. Clinical trials show its efficacy in actively accelerating wound healing, increasing wound tearing-resistance, and reducing, even avoiding, scar proliferation in burn
patients. Genfulin^® is used in the treatment of deep II-degree burns and wound healing.

Strengths:
          *   100 μg rhGM-CSF/10g/tube